Valeant’s Stock Becomes (Relatively) Quiet After Wild Year

  • Shares at smallest equivalent volatility range since 2013
  • Canadian drugmaker earnings report scheduled for Oct. 19

After a yearlong, up-and-down ride, shares of Valeant Pharmaceuticals International Inc. are enjoying a period of relative calm. 

To continue reading this article you must be a Bloomberg Professional Service Subscriber.